Different Dietary n-3 Polyunsaturated Fatty Acid Formulations Distinctively Modify Fatty Acid and N-Acylethanolamine Profiles in Rat Brain. (7th June 2021)

• Record Type: Journal Article
• Authors: Murru, Elisabetta; Carta, Gianfranca; Abolghasemi, Armita; Manca, Claudia; Prates, José AM; Guil-Guerrero, José L; Banni, Sebastiano; Lopes, Paula A
• Is Part Of: Current developments in nutrition. Volume 5(2021)Supplement 2
• Page Start: 349
• Page End: 349
• Publication Date: 2021-06-07
• Subjects: Nutrition -- Periodicals; Nutritional Physiological Phenomena; Nutrition; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 612.3
• DOI: 10.1093/cdn/nzab037_059
• Languages: English
• ISSNs: 2475-2991

Abstract

Abstract: Objectives: Dietary n-3 polyunsaturated fatty acids (n-3PUFA) may influence the brain fatty acid (FA) profile and, thereby, the biosynthesis of FA bioactive metabolite, such as N-acylethanolamines (NAE). We investigated the influence of different dietary formulation of n-3PUFA from vegetable or marine oils on rat FA incorporation and modulation of NAE biosynthesis. Methods: Rats were fed for 10 weeks with diets containing 12% of fat from milk + 4% soybean oil and 4% of oils with different n-3 PUFA species: soybean oil as control (MilkFat), linseed oil with α-linolenic (ALA) (LSO), Buglossoides arvensis oil with ALA and stearidonic (SDA) (Buglos), fish oil with EPA and DHA (FO), Nannochloropsis microalga oil with EPA (Nanno) or Schizochytrium microalga oil with DHA (Schy). Brain FA and NAE profile were assessed LC-DAD-MS/MS. Statistical Kruskal-Wallis test followed by Dunn's correction was applied. Results: Different dietary n-3PUFA formulations induced FA change in the brain, compared to MilkFat group, DHA levels remained unchanged despite its elevated intake with FO and Schy diets. However, we found 9 fold ( P < 0.001) increase of EPA with FO, arachidonic (AA) decreased significantly about 16% ( P < 0.05) with LSO and FO diets. n-6 PUFA docosatetraenoic (DTA) (26% P < 0.05) and docosapentaenoic (DPA) (73% P < 0.05) were reduced with FO, probably due to a competition with EPA in the incorporation into phospholipids. We observed a 44% ( P < 0.05) significant decrease of N-arachidonoylethanolamine (AEA) with LSO and FO, and a reduction of N-linoleoylethanolamine (LEA) by 49% ( P < 0.05) with LSO. On the other hand, we found an increase of N-eicosapentanoylethanolamine (EPEA), derived from EPA, by 225% ( P < 0.05) with FO, compared to MilkFat group. Conclusions: Our data indicate that reduction of AEA levels might attenuate its effects on the CB1 cannabinoid receptors, the main molecular target of the endogenous partial agonist AEA, which regulate physiological processes in the central nervous system. Therefore, in those pathophysiological conditions where is desirable to downregulate an overactive endocannabinoid system, a mixture of EPA and DHA as in FO, and ALA as in LSO, may potentially be a preferred nutritional source of n-3 PUFA. Funding Sources: University of Cagliari (FIR 2019) and Fundação FCT (Portugal).